PPD
+0.00%(+0.00)
Open
47.32
Prev Close
47.28
Day High
47.40
Day Low
47.24
Volume
1.9M
Avg Volume
1.4M
52W High
47.41
52W Low
31.54
Signal
Leaning Bullish1
Price
1
Move+0.00%Quiet session
Volume
1
Volume1.3× avgNormal activity
Technical
1
RSIRSI 55Momentum positive
PRICE
Prev Close
47.28
Open
47.32
Day Range47.24 – 47.40
47.24
47.40
52W Range31.54 – 47.41
31.54
47.41
99% of range
VOLUME & SIZE
Avg Volume
1.4M
FUNDAMENTALS
P/E Ratio
0.0x
Value territory
EPS (TTM)
Div Yield
No dividend
Quick Read
TrendInsufficient MA data
Momentum
BULLISH
revenue +35% YoY
Valuation
FAIR
P/E not available
Health
MODERATE
CR 1.1 · FCF $0.25/sh
Bullish
Key MetricsTTM
Market Cap$0.00
Revenue TTM$5.88B
Net Income TTM$364.06M
Free Cash Flow$434.13M
Gross Margin38.4%
Net Margin3.3%
Operating Margin10.9%
Return on Equity-8.9%
Return on Assets2.4%
Debt / Equity-5.96
Current Ratio1.12
EPS TTM$0.44

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong4 watch1 concern
40/100
Liquidity
1.12Watch
Leverage
-5.96Strong
Coverage
2.3xWatch
ROE
-8.9%Concern
ROIC
11.1%Watch
Cash
$768MWatch
ANALYST COVERAGE14 analysts
HOLD
-15.4%downside to target
Buy
643%
Hold
857%
6 Buy (43%)8 Hold (57%)0 Sell (0%)
Full report →
Stock Health
Composite Score
2 of 4 signals bullish
8/10
Technicals
RSI RangeRSI 55 — Bullish momentum
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusHold
~
LiquidityCurrent Ratio 1.12
~

1 signal unavailable — limited data for this stock

Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
PDividend PaymentOct 20, 2026
In 170 days
Technicals
Technical SetupBULLISH
Technicals →

Trend

UptrendGolden Cross · 50D leads 200D by 5.1%

+0.4% vs SMA 50 · +5.4% vs SMA 200

Momentum

RSI54.9
Neutral territory
MACD+0.04
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$47.41+0.3%
Current
$47.28
EMA 50
$47.07-0.4%
52W Low
$31.54-33.3%
EMA 200
$30.75-35.0%
52-Week RangeNear 52-week high
$31.5499th %ile$47.41
Earnings & Analysts
🔥Beat 4 consecutive quarters
Earnings HistoryPPD
Last 8Q
+12.1%avg beat
Beat 7 of 8 quartersMissed 1 Estimates rising
+22%
Q1'20
+14%
Q2'20
+14%
Q3'20
-6%
Q4'20
+8%
Q1'21
+13%
Q2'21
+18%
Q3'21
+13%
Q4'21
Beat
Miss
Estimate
Deeper color = bigger beat/miss
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
H&f Corporate Inves…10 Percent Own…
$7.5M
Dec 8
SELL
Simmons David SCEO
$4.2M
Apr 14
SELL
Simmons David SCEO
$872K
Mar 17
SELL
Johnston David Mich…See Remarks
$821K
Mar 17
SELL
Garrow Ronald ESee Remarks
$2.5M
Mar 2
SELL
Johnston David Mich…See Remarks
$1.4M
Mar 1
SELL
Financials

INSTITUTIONAL OWNERSHIP

1
Carroll Financial Associates, Inc.
0
2
SPHINX TRADING, LP
0
3
H&F Corporate Investors VII, Ltd.
77.1M
4
Omni Partners US LLC
674K
5
Marshall Wace North America L.P.
155K
6
Berman Capital Advisors, LLC
58
7
PICTET ASSET MANAGEMENT LTD
41K
8
FIRST HORIZON CORP
8
News & Activity

PPD News

20 articles · 4h ago

About

PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Company's customers include pharmaceutical, biotechnology, medical device, academic and government organization s. With offices in 46 countries and more than 26,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.